BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Brincidofovir

Incresed Risk for Mortality When Used For Longer Duration

  • An increased incidence of mortality was seen in TEMBEXAtreated subjects compared to placebo-treated subjects in a 24-week clinical trial when TEMBEXA was evaluated in another disease

Patient Counseling Information

Package Inserts

Brincidofovir

Updated July 2021